| Ident. | Authors (with country if any) | Title |
|---|
| 000680 (2017) |
Gale E. Smith [États-Unis] ; Xiangjie Sun [États-Unis] ; Yaohui Bai [États-Unis] ; Ye V. Liu [États-Unis] ; Michael J. Massare [États-Unis] ; Melissa B. Pearce [États-Unis] ; Jessica A. Belser [États-Unis] ; Taronna R. Maines [États-Unis] ; Hannah M. Creager [États-Unis] ; Gregory M. Glenn [États-Unis] ; David Flyer [États-Unis] ; Peter Pushko [États-Unis] ; Min Z. Levine [États-Unis] ; Terrence M. Tumpey [États-Unis] | Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets |
| 000752 (2017) |
Tor Kristian Andersen [Norvège] ; Fan Zhou [Norvège] ; Rebecca Cox [Norvège] ; Bjarne Bogen [Norvège] ; Gunnveig Gr Deland [Norvège] | A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza |
| 000848 (2016) |
Gi-Ja Lee [Corée du Sud] ; Fu-Shi Quan [Corée du Sud] | Protection induced by early stage vaccination with pandemic influenza virus-like particles. |
| 000903 (2016) |
Tao Cheng [République populaire de Chine] ; Xiang Wang [République populaire de Chine] ; Yufeng Song [République populaire de Chine] ; Xinying Tang [République populaire de Chine] ; Chao Zhang [République populaire de Chine] ; Hongbo Zhang [République populaire de Chine] ; Xia Jin [République populaire de Chine] ; Dongming Zhou [République populaire de Chine] | Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1. |
| 000A96 (2015) |
Chantal J. Snoeck [Luxembourg (pays)] ; Olusoji J. Abiola [Nigeria] ; Aurélie Sausy [Luxembourg (pays)] ; Mbah P. Okwen [Cameroun] ; Ayoade G. Olubayo [Nigeria] ; Ademola A. Owoade [Nigeria] ; Claude P. Muller [Luxembourg (pays)] | Serological evidence of pandemic (H1N1) 2009 virus in pigs, West and Central Africa. |
| 000B52 (2015) |
Michela Brazzoli [Italie] ; Diletta Magini [Italie] ; Alessandra Bonci [Italie] ; Scilla Buccato [Italie] ; Cinzia Giovani [Italie] ; Roland Kratzer [Italie] ; Vanessa Zurli [Italie] ; Simona Mangiavacchi [Italie] ; Daniele Casini [Italie] ; Luis M. Brito [États-Unis] ; Ennio De Gregorio [Italie] ; Peter W. Mason [États-Unis] ; Jeffrey B. Ulmer [États-Unis] ; Andrew J. Geall [États-Unis] ; Sylvie Bertholet [Italie] | Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin |
| 000B56 (2015) |
Timo Vesikari [États-Unis] ; Jan Hendrik Richardus ; Johan Berglund ; Tiina Korhonen ; Carl-Erik Flodmark ; Ann Lindstrand ; Sven Arne Silfverdal ; Vinod Bambure ; Adrian Caplanusi ; Ilse Dieussaert ; Sumita Roy-Ghanta ; David W. Vaughn | Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials. |
| 000B59 (2015) |
Björn F. Koel [Pays-Bas] ; Ramona Mögling [Pays-Bas, Royaume-Uni] ; Salin Chutinimitkul [Pays-Bas] ; Pieter L. Fraaij [Pays-Bas] ; David F. Burke [Royaume-Uni] ; Stefan Van Der Vliet [Pays-Bas] ; Emmie De Wit [Pays-Bas] ; Theo M. Bestebroer [Pays-Bas] ; Guus F. Rimmelzwaan [Pays-Bas] ; Albert D. M. E. Osterhaus [Pays-Bas] ; Derek J. Smith [Royaume-Uni, Pays-Bas] ; Ron A. M. Fouchier [Pays-Bas] ; Miranda De Graaf [Pays-Bas, Royaume-Uni] | Identification of Amino Acid Substitutions Supporting Antigenic Change of Influenza A(H1N1)pdm09 Viruses |
| 000E53 (2014) |
Surender Khurana [États-Unis] ; Elizabeth M. Coyle [États-Unis] ; Swati Verma [États-Unis] ; Lisa R. King [États-Unis] ; Jody Manischewitz [États-Unis] ; Corey J. Crevar [États-Unis] ; Donald M. Carter [États-Unis] ; Ted M. Ross [États-Unis] ; Hana Golding [États-Unis] | H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine. |
| 000E83 (2014) |
Attapon Kamlangdee [États-Unis] ; Brock Kingstad-Bakke [États-Unis] ; Tavis K. Anderson [États-Unis] ; Tony L. Goldberg [États-Unis] ; Jorge E. Osorio [États-Unis] | Broad Protection against Avian Influenza Virus by Using a Modified Vaccinia Ankara Virus Expressing a Mosaic Hemagglutinin Gene |
| 001257 (2013) |
Byoung-Shik Shim [Corée du Sud] ; Jung-Ah Choi ; Ho-Hyun Song ; Sung-Moo Park ; In Su Cheon ; Ji-Eun Jang ; Sun Je Woo ; Chung Hwan Cho ; Min-Suk Song ; Hyemi Kim ; Kyung Joo Song ; Jae Myun Lee ; Suhng Wook Kim ; Dae Sub Song ; Young Ki Choi ; Jae-Ouk Kim ; Huan Huu Nguyen ; Dong Wook Kim ; Young Yil Bahk ; Cheol-Heui Yun ; Man Ki Song | Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus. |
| 001268 (2013) |
Mariana Baz ; Myeisha Paskel ; Yumiko Matsuoka ; James Zengel ; Xing Cheng ; Hong Jin ; Kanta Subbarao | Replication and Immunogenicity of Swine, Equine, and Avian H3 Subtype Influenza Viruses in Mice and Ferrets |
| 001345 (2013) |
Hao Wang ; Chi Ma ; Yanlai Lu ; Xu Ji ; Yongsheng Pang ; Fang Hua ; Lianxian Cui ; Denian Ba ; Wei He | Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes |
| 001B09 (2012) |
Kelvin K. W. To ; Anna J. X. Zhang ; Ivan F. N. Hung [République populaire de Chine] ; Ting Xu ; Whitney C. T. Ip ; Rebecca T. Y. Wong ; Joseph C. K. Ng ; Jasper F. W. Chan ; Kwok-Hung Chan ; Kwok-Yung Yuen | High Titer and Avidity of Nonneutralizing Antibodies against Influenza Vaccine Antigen Are Associated with Severe Influenza |
| 001B40 (2012) |
Ralf Wagner [Allemagne] ; Constanze Göpfert ; Joanna Hammann ; Britta Neumann ; John Wood ; Robert Newman ; Chantal Wallis ; Nina Alex ; Michael Pfleiderer | Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach. |
| 001C00 (2012) |
H. Czajka [Pologne] ; S. Unal ; S. Ulusoy ; G. Usluer ; A. Strus ; E. Sennaroglu ; J. Guzik ; A. Topeli Iskit ; A. Dargiewicz ; D. Musial ; R. Caylan ; J. Dziduch ; E. Eskioglu ; B. Hasiec ; E. Cwinarowiczliwa ; R. Belli ; I A Abdel-Messih ; J. Beygo ; E. Fragapane | A phase II, randomised clinical trial to demonstrate the non-inferiority of low-dose MF59-adjuvanted pre-pandemic A/H5N1 influenza vaccine in adult and elderly subjects. |
| 001C05 (2012) |
Walter Wodal [Autriche] ; Falko G. Falkner ; Astrid Kerschbaum ; Claudia Gaiswinkler ; Richard Fritz ; Stefan Kiermayr ; Daniel Portsmouth ; Helga Savidis-Dacho ; Sogue Coulibaly ; Christina Piskernik ; Christine Hohenadl ; M Keith Howard ; Otfried Kistner ; P Noel Barrett ; Thomas R. Kreil | A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate. |
| 002347 (2011) |
Isaac Sipo [Allemagne] ; Mathias Knauf ; Henry Fechner ; Wolfgang Poller ; Oliver Planz ; Reinhard Kurth ; Stephen Norley | Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). |
| 002487 (2011) |
George Risi [États-Unis] ; Louise Frenette ; Joanne M. Langley ; Ping Li ; Dennis Riff ; Eric Sheldon ; David W. Vaughn ; Louis Fries | Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months. |
| 002538 (2011) |
Koert J. Stittelaar [Pays-Bas] ; Edwin J B. Veldhuis Kroeze ; Larisa Rudenko ; Rajeev Dhere ; Sit Thirapakpoomanunt ; Marie Paule Kieny ; Albert D M E. Osterhaus | Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets. |
| 003249 (2010) |
Nicolas Sabarth [Autriche] ; M Keith Howard ; Helga Savidis-Dacho ; André Van Maurik ; P Noel Barrett ; Otfried Kistner | Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. |
